ClinicalTrials.govpublic full text
Trial of TRC105 and Sorafenib in Patients With HCC
hepatocellular carcinoma, trc105, cd105, endoglin, angiogenesis inhibitor, hcc, tki, tyrosine kinase inhibitor, sorafenib, nexavar, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 811884
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.